FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
ROSE WILLIAM
  2. Issuer Name and Ticker or Trading Symbol
REATA PHARMACEUTICALS INC [RETA] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last)
(First)
(Middle)
4215 WEST LOVERS LANE, SUITE 200		 3. Date of Earliest Transaction (Month/Day/Year)
09/15/2023
(Street)

DALLAS, TX 75209		 4. If Amendment, Date Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4) 		7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5) 		6. Date Exercisable and Expiration Date
(Month/Day/Year) 		7. Title and Amount of Underlying Securities
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4) 		10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4) 		11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Class B Common Stock (13) 09/15/2023   G(1)     29,000   (13)   (13) Class A common stock 29,000 $ 0 1,848,998 I By Trust (6)
Class B Common Stock (13) 09/15/2023   G(2)     29,000   (13)   (13) Class A common stock 29,000 $ 0 1,819,998 I By Trust (6)
Class B Common Stock (13) 09/15/2023   G(3)     29,000   (13)   (13) Class A common stock 29,000 $ 0 1,790,998 I By Trust (6)
Class B Common Stock (13) 09/15/2023   G(3) V 29,000     (13)   (13) Class A common stock 29,000 $ 0 29,000 I By Trust (7)
Class B Common Stock (13) 09/15/2023   G(4)     29,000   (13)   (13) Class A common stock 29,000 $ 0 1,761,998 I By Trust (6)
Class B Common Stock (13) 09/15/2023   G(4) V 29,000     (13)   (13) Class A common stock 29,000 $ 0 29,215 I By Trust (8)
Class B Common Stock (13) 09/15/2023   G(5)     29,000   (13)   (13) Class A common stock 29,000 $ 0 1,732,998 I By Trust (6)
Class B Common Stock (13) 09/15/2023   G(5) V 29,000     (13)   (13) Class A common stock 29,000 $ 0 29,492 I By Trust (9)
Class B Common Stock (13)               (13)   (13) Class A common stock 129,308   129,308 D (10)  
Class B Common Stock (13)               (13)   (13) Class A common stock 87,776   87,776 I See Footnote (11)
Class B Common Stock (13)               (13)   (13) Class A common stock 313   313 I See Footnote (12)

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
ROSE WILLIAM
4215 WEST LOVERS LANE, SUITE 200
DALLAS, TX 75209		   X      

Signatures

 /s/ Charles E. Gale, Attorney-In-Fact for William E. Rose   09/19/2023
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) This transaction represents the donative transfer of shares of Class B common stock. On September 15, 2023, these 29,000 shares were transferred from the Evelyn Potter Rose Survivor's Trust to a family trust.
(2) This transaction represents the donative transfer of shares of Class B common stock. On September 15, 2023, these 29,000 shares were transferred from the Evelyn Potter Rose Survivor's Trust to a family trust.
(3) This transaction represents the donative transfer of shares of Class B common stock. On September 15, 2023, these 29,000 shares were transferred from the Evelyn Potter Rose Survivor's Trust to the Edward Alexander Rose 1999 Trust, for which William E. Rose serves as co-trustee.
(4) This transaction represents the donative transfer of shares of Class B common stock. On September 15, 2023, these 29,000 shares were transferred from the Evelyn Potter Rose Survivor's Trust to the Charles Henry Rose 2001 Trust.
(5) This transaction represents the donative transfer of shares of Class B common stock. On September 15, 2023, these 29,000 shares were transferred from the Evelyn Potter Rose Survivor's Trust to the John William Rose 2002 Trust.
(6) These shares are owned directly by the Evelyn Potter Rose Survivor's Trust, for which Charles E. Gale and Evelyn P. Rose serve as co-trustees.
(7) These shares are owned indirectly by William E. Rose, a director of the Issuer, as co-trustee of the Edward Alexander Rose 1999 Trust.
(8) These shares are owned indirectly by William E. Rose, a director of the Issuer, as co-trustee of the Charles Henry Rose 2001 Trust.
(9) These shares are owned indirectly by William E. Rose, a director of the Issuer, as co-trustee of the John William Rose 2002 Trust.
(10) These shares are owned directly by William E. Rose, a director of the Issuer.
(11) These shares are owned directly by the Evelyn P. Rose Fidelity SEP IRA and indirectly by Evelyn R. Rose.
(12) These shares are owned directly by the Charles E. Gale Fidelity Rollover IRA and indirectly by Charles E. Gale.
(13) The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.